NL193191C - 1,3-Oxazolidine-2-on-derivaten en farmaceutisch preparaat dat een dergelijke verbinding bevat. - Google Patents

1,3-Oxazolidine-2-on-derivaten en farmaceutisch preparaat dat een dergelijke verbinding bevat. Download PDF

Info

Publication number
NL193191C
NL193191C NL8501579A NL8501579A NL193191C NL 193191 C NL193191 C NL 193191C NL 8501579 A NL8501579 A NL 8501579A NL 8501579 A NL8501579 A NL 8501579A NL 193191 C NL193191 C NL 193191C
Authority
NL
Netherlands
Prior art keywords
compound
oxazolidin
phenyl
toluene
mixture
Prior art date
Application number
NL8501579A
Other languages
English (en)
Dutch (nl)
Other versions
NL193191B (nl
NL8501579A (nl
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of NL8501579A publication Critical patent/NL8501579A/nl
Publication of NL193191B publication Critical patent/NL193191B/xx
Application granted granted Critical
Publication of NL193191C publication Critical patent/NL193191C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL8501579A 1984-09-28 1985-05-31 1,3-Oxazolidine-2-on-derivaten en farmaceutisch preparaat dat een dergelijke verbinding bevat. NL193191C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59203624A JPS6183170A (ja) 1984-09-28 1984-09-28 新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法
JP20362484 1984-09-28

Publications (3)

Publication Number Publication Date
NL8501579A NL8501579A (nl) 1986-04-16
NL193191B NL193191B (nl) 1998-10-01
NL193191C true NL193191C (nl) 1999-02-02

Family

ID=16477122

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8501579A NL193191C (nl) 1984-09-28 1985-05-31 1,3-Oxazolidine-2-on-derivaten en farmaceutisch preparaat dat een dergelijke verbinding bevat.

Country Status (27)

Country Link
US (1) US4644063A (it)
JP (1) JPS6183170A (it)
KR (1) KR900004323B1 (it)
AR (1) AR240924A1 (it)
AT (1) AT392069B (it)
AU (1) AU566419B2 (it)
BR (1) BR8502707A (it)
CA (1) CA1252092A (it)
CH (1) CH663207A5 (it)
CS (1) CS273606B2 (it)
DE (1) DE3519261C2 (it)
DK (1) DK165952C (it)
ES (2) ES8800571A1 (it)
FR (1) FR2571052B1 (it)
GB (2) GB8512975D0 (it)
HU (1) HU199132B (it)
IN (1) IN162060B (it)
IT (1) IT1208807B (it)
MX (2) MX161397A (it)
MY (1) MY102081A (it)
NL (1) NL193191C (it)
NZ (1) NZ212143A (it)
PH (1) PH20852A (it)
RO (1) RO91422B (it)
SE (1) SE463100B (it)
SU (2) SU1402263A3 (it)
ZA (1) ZA854001B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6183147A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤
JPH0759570B2 (ja) * 1986-05-06 1995-06-28 三井東圧化学株式会社 ２−オキサゾリジノン類の製造方法
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
EP0307141B1 (en) * 1987-09-10 1993-01-13 MERCK SHARP & DOHME LTD. Oxazoles and thiazoles for the treatment of senile dementia
ATE106243T1 (de) * 1988-03-24 1994-06-15 Sankyo Co Verwendung von isoxazolinonen als cerebro-aktive medikamente.
JPH0314562A (ja) * 1988-04-11 1991-01-23 Nippon Chemiphar Co Ltd 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
DE69320730T2 (de) * 1992-07-14 1999-02-11 Nippon Chemiphar Co Alkylendiaminderivate
AU682889B2 (en) * 1993-09-15 1997-10-23 Merck Sharp & Dohme Limited Imidazolone and oxazolone derivatives as dopamine antagonists
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
US6037354A (en) 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
PL2967029T3 (pl) 2013-03-14 2017-10-31 Akzo Nobel Chemicals Int Bv Eter celulozy jako środek kontrolujący znoszenie i środek odporności na deszcz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437389A (en) * 1948-03-09 Oxazoeidones and erocesstok
DE1135461B (de) * 1959-05-08 1962-08-30 Knoll Ag Verfahren zur Herstellung von basisch substituierten Phthalimidinen
FR1301267A (fr) * 1961-04-04 1962-08-17 Science Union Et Compagnie Soc Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation
US3131197A (en) * 1963-03-13 1964-04-28 Smith Kline French Lab 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
FR2179582B1 (it) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
GB2165237A (en) 1986-04-09
ES8800571A1 (es) 1987-11-01
SE8502525L (sv) 1986-03-29
DK165952C (da) 1993-07-05
ES543517A0 (es) 1987-11-01
US4644063A (en) 1987-02-17
SU1402263A3 (ru) 1988-06-07
AR240924A1 (es) 1991-03-27
MY102081A (en) 1992-03-31
CA1252092A (en) 1989-04-04
MX161397A (es) 1990-09-20
GB8512975D0 (en) 1985-06-26
DK165952B (da) 1993-02-15
MX21592A (es) 1994-01-31
AR240924A2 (es) 1991-03-27
RO91422B (ro) 1987-07-02
GB2165237B (en) 1987-12-09
KR900004323B1 (ko) 1990-06-22
DK230185A (da) 1986-03-29
FR2571052A1 (fr) 1986-04-04
NZ212143A (en) 1987-11-27
ES557075A0 (es) 1988-04-01
AU566419B2 (en) 1987-10-22
SU1431679A3 (ru) 1988-10-15
NL193191B (nl) 1998-10-01
JPH0469150B2 (it) 1992-11-05
SE8502525D0 (sv) 1985-05-22
CH663207A5 (fr) 1987-11-30
HU199132B (en) 1990-01-29
DE3519261C2 (de) 1997-01-16
IT8567500A0 (it) 1985-05-30
IN162060B (it) 1988-03-19
PH20852A (en) 1987-05-19
NL8501579A (nl) 1986-04-16
HUT39168A (en) 1986-08-28
SE463100B (sv) 1990-10-08
BR8502707A (pt) 1986-05-27
JPS6183170A (ja) 1986-04-26
AU4469785A (en) 1986-04-10
AT392069B (de) 1991-01-25
ATA165685A (de) 1990-07-15
KR860002502A (ko) 1986-04-26
DE3519261A1 (de) 1986-04-10
DK230185D0 (da) 1985-05-23
RO91422A (ro) 1987-06-30
CS273606B2 (en) 1991-03-12
IT1208807B (it) 1989-07-10
GB8513685D0 (en) 1985-07-03
ZA854001B (en) 1986-01-29
ES8802152A1 (es) 1988-04-01
CS392785A2 (en) 1990-08-14
FR2571052B1 (fr) 1988-03-04

Similar Documents

Publication Publication Date Title
NL193191C (nl) 1,3-Oxazolidine-2-on-derivaten en farmaceutisch preparaat dat een dergelijke verbinding bevat.
SU1160935A3 (ru) Способ получени производных бензазепина или их кислотно-аддитивных солей с неорганическими кислотами
KR0130976B1 (ko) 3-[4-(1-치환된-4-피페라지닐)부틸]-4-티아졸리디논, 이의 제조방법 및 이를 포함하는 약제학적 조성물
FR2518993A1 (fr) 2-(4-((4,4-dialkyl-2,6-piperidinedion-1-yl))-1-piperazinyl) pyrimidines, leur preparation et leur application pharmacologique
FR2501207A1 (fr) Composes quinazoliniques antitumoraux et leur procede de production
JPS5825657B2 (ja) シンキビス − アルカノ−ルアミンルイノ セイゾウホウホウ
US5332754A (en) Naphthyloxazolidone derivatives
NZ238557A (en) N-substituted (5-phenyl (and -naphthyl)(methyl)dioxan-2-yl alkyl)amine, amide and carbamate derivatives; preparatory processes and pharmaceutical compositions
EP0177245B1 (en) Amino-alcohol derivatives and processes for their preparation
CA1125752A (en) 3,3-dichloro-2-azetidinone derivatives
AU4281399A (en) Chemical synthesis of morpholine derivatives
US4151169A (en) Process for preparing substituted 1,2,4-triazole derivatives
EP0187700B1 (en) Novel aminoalkyl substituted urea derivatives, acid addition salts thereof and enatiomers
JP2909151B2 (ja) ピリドベンゾインドール、その製造方法及びそれを含有する組成物
FR2650591A1 (fr) Nouveaux derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CZ15997A3 (en) 3-substituted derivatives of 3h-2-3-benzodiazepine, process of their preparation, their use in medicaments and pharmaceutical composition containing thereof
EP0376633B1 (en) Benzoxazepine derivatives
JPS6045878B2 (ja) Ｎ，ｎ’−二置換環状ジアミン及び精神病治療用薬剤
IL46157A (en) N-(2-morpholinylmethyl)derivatives of bicyclic n-heterocyclic ketones
JPS6228146B2 (it)
NZ210123A (en) Thiadiazinone derivatives and pharmaceutical compositions
US3917633A (en) 9-{8 3-(Dimethylamino)-propylidene{9 -9H-dibenzo{8 c,f{9 -imidazol{8 1,2-a{9 azepines
JP2865341B2 (ja) ベンゾオキサゼピン誘導体
US4039551A (en) 1-[(Hydroxyamino)methyl]-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
Kodonidi et al. Optimized Synthesis of the O-Benzoylaminobenzoic Acid Derivative 2-Benzoylamino-N-[4-(4, 6-Dimethylpyrimidin-2-Ylsulfamoyl) Phenyl] Benzamide Possessing Anxiolytic Activity

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 20001201